GSK raises stake in Theravance

Monday 2 April 2012

For the second time in a little more than a year, GlaxoSmithKline Plc has raised its stake in Theravance Inc of the US with whom it has collaborations for late-stage products for chronic obstructive pulmonary disease (COPD) and asthma.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom